Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?

Pfizer’s (PFE) stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ups and downs in between, after it took a hammering in the past couple of years due to declining sales of its COVID products with the end of the pandemic.After witnessing possibly its worst slowdown in 2023/2024, the company seems to be gradually making a comeback and entering a transition phase. Its non-COVID drugs and contributions from new and newly acquired products have started t ...